Erik van Helden

DRS.

20152019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2019

  • 7 Article
  • 1 Meeting Abstract
  • 1 Review article

Decalcification of Breast Cancer Bone Metastases with EDTA Does Not Affect ER, PR, and HER2 Results

van Es, S. C., van der Vegt, B., Bensch, F., Gerritse, S., van Helden, E. J., Boon, E., Angus, L., Overbosch, J., Menke-van der Houven van Oordt, C. W., Verheul, H. M., van Herpen, C. M. L., Jager, A., Oosting, S. F., de Vries, E. G. E. & Schröder, C. P., 2019, In : American Journal of Surgical Pathology.

Research output: Contribution to journalArticleAcademicpeer-review

RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer

van Helden, E. J., Angus, L., Menke-van der Houven van Oordt, C. W., Heideman, D. A. M., Boon, E., van Es, S. C., Radema, S. A., van Herpen, C. M. L., de Groot, D. J. A., de Vries, E. G. E., Jansen, M. P. H. M., Sleijfer, S. & Verheul, H. M. W., 26 Jul 2019, In : Molecular oncology.

Research output: Contribution to journalArticleAcademicpeer-review